Achieving Lean Processing With Single-Use Systems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Achieving Lean Processing With Single-Use Systems


Pharmaceutical Technology Europe


Single-use filtration and fill–finish technologies can be used as part of a lean manufacturing strategy to boost production, and reduce manufacturing waste and costs.


(IMAGE SOURCE/GETTY IMAGES)
Single-use manufacturing solutions can accelerate production, improve flexibility, and reduce costs and waste–benefits that are well-aligned with lean process initiatives. Based on principles largely developed by Toyota, lean manufacturing seeks to identify and eliminate waste in manufacturing processes to reduce the cost of bringing a product to market (1). Focusing on creating more value with less work, lean manufacturing generally focuses on reducing eight specified wastes (see Table 1).


Table 1: Eight types of wastes targeted by lean process initiatives.
Implementing single-use filtration and fill–finish systems can deliver lean process improvement efficiencies and eliminate waste from the manufacturing workflow. Single-use systems can speed up production processes, reduce the risk of deviations, maintain consistency and have a positive impact on the bottom-line.

Delivering value with single-use filtration

Single-use filtration systems can deliver value in a number of ways. However, it is particularly beneficial if the single-use system has a modular structure that is replicable and scalable across different geographies, as this means the filtration assembly can keep pace with changing product, scale and site requirements.

Lean processing

As will be demonstrated later in a fill–finish case study, single-use assemblies can reduce processing time by as much as 50% through decreased preparation and set-up times. A number of elements drive these reductions, such as:

  • modular manifold designs mean they can be built on site and scaled as required
  • bags can be designed such that filling processes eliminate the need for operator handling
  • sterile filtration assemblies can facilitate technology transfer between early development, late development and commercial manufacturing
  • innovations in disconnection technology can reduce the time required to make sterile disconnection compared with the time taken by traditional tube sealers.

Before implementing single-use technologies, a thorough assessment of the current processes and opportunities for improvement should be conducted and objectives should be clearly defined. It is also important to pilot solutions and conduct performance testing in a laboratory setting before a definitive solution is finalised. Technology experts should also review process parameters, such as flow rate and pressuredrop requirements, and recommend the appropriate filter membrane and size when designing filtration subassemblies. Hands-on testing prior to installation will also give operators a greater degree of confidence than a typical new processing setup might usually foster, and will also give them the opportunity for real-time feedback, which will enable the solution to be better adapted to their actual process.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology Europe,
Click here